BTIG reiterates Buy rating on Abivax, $175 target
BTIG reiterated a Buy rating on Abivax and set a $175.00 price target, implying 93.1% upside from the Sep 21 close of $90.65.
BTIG reiterated a Buy rating on Abivax and set a $175.00 price target, implying 93.1% upside from the Sep 21 close of $90.65.